TickerFactsScreenerDevelopers

INTEGRATED BIOPHARMA INC (INBP) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2011: $392.0K2012: -$771.0K2013: -$1.44M2014: $1.88M2015: -$113.0K2017: $397.0K2018: $1.17M2019: $328.0K2020: $1.34M2021: $3.05M2022: $4.09M2023: $1.23M2024: $943.0K2025: $2.06M$2.06M
2011Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025$2.06M+119.0%
2024$943.0K-23.5%
2023$1.23M-69.9%
2022$4.09M+34.1%
2021$3.05M+127.8%
2020$1.34M+308.2%
2019$328.0K-71.9%
2018$1.17M+194.2%
2017$397.0K—
2015-$113.0K-106.0%
2014$1.88M+230.5%
2013-$1.44M-86.5%
2012-$771.0K-296.7%
2011$392.0K—